Catalyst Wire Dossier Catalyst Wire Dossier

Floseal Matrix

gelatin-thrombin matrix hemostatic agent · Baxter International Corporation
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Floseal Matrix, covering 2014-03-05 to 2014-06-25. Get the full timeline:

Most recent: Clinical Trial Update: Ovarian Reserve After Ovarian Hemostasis by Floseal Matrix [Phase 3]

See pricing